| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Allogene Therapeutics, Inc.
13G/A
Amendment 11
ALLO · 019770106
|
3.9% |
8/7/2026
Event 6/30/2026
|
|||
| Arie Belldegrun, M.D. | 3.9% | ||||
| Bellco Legacy LLC | 0.2% | ||||
| Bellco Legacy IV LLC | 1.3% | ||||
| Vida Ventures LLC | 0.5% | ||||
| Vida Ventures III, L.P. | 0.5% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 10
ALLO · 019770106
|
5.4% |
5/13/2026
Event 3/31/2026
|
|||
| Arie Belldegrun, M.D. | 5.4% | ||||
| Bellco Legacy LLC | 0.2% | ||||
| Bellco Legacy IV LLC | 1.9% | ||||
| Vida Ventures LLC | 0.7% | ||||
| Vida Ventures III, L.P. | 0.7% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 9
ALLO · 019770106
|
5.8% |
2/17/2026
Event 12/31/2025
|
|||
| Arie Belldegrun, M.D. | 5.8% | ||||
| Bellco Legacy LLC | 0.2% | ||||
| Bellco Legacy IV LLC | 2.1% | ||||
| Vida Ventures LLC | 0.8% | ||||
| Vida Ventures III, L.P. | 0.8% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 8
ALLO · 019770106
|
5.6% |
11/13/2025
Event 9/30/2025
|
|||
| Arie Belldegrun, M.D. | 5.6% | ||||
| Bellco Legacy LLC | 0.2% | ||||
| Bellco Legacy IV LLC | 2.1% | ||||
| Vida Ventures LLC | 0.8% | ||||
| Vida Ventures III, L.P. | 0.8% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 7
ALLO · 019770106
|
5.7% |
8/12/2025
Event 6/30/2025
|
|||
| Arie Belldegrun, M.D. | 5.7% | ||||
| Bellco Legacy LLC | 0.2% | ||||
| Bellco Legacy IV LLC | 2.1% | ||||
| Vida Ventures LLC | 0.8% | ||||
| Vida Ventures III, L.P. | 0.8% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 6
ALLO · 019770106
|
5.7% |
5/9/2025
Event 3/31/2025
|
|||
| Arie Belldegrun, M.D. | 5.7% | ||||
| Bellco Legacy LLC | 0.2% | ||||
| Bellco Legacy IV LLC | 2.1% | ||||
| Vida Ventures LLC | 0.8% | ||||
| Vida Ventures III, L.P. | 0.8% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
|
Allogene Therapeutics, Inc.
13G/A
Amendment 5
ALLO · 019770106
|
5.8% |
2/13/2025
Event 12/31/2024
|
|||
| Arie Belldegrun, M.D. | 5.8% | ||||
| Bellco Legacy LLC | 0.3% | ||||
| Bellco Legacy IV LLC | 2.2% | ||||
| Vida Ventures LLC | 0.8% | ||||
| Vida Ventures III, L.P. | 0.8% | ||||
| Vida Ventures III-A, L.P. | 0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.